@article{692b73c01b474d3b9991f5668e31cd31,
title = "Hodgkin Lymphoma, version 2.2015",
abstract = "Hodgkin lymphoma (HL) is an uncommon malignancy involving lymph nodes and the lymphatic system. Classical Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma are the 2 main types of HL. CHL accounts for most HL diagnosed in the Western countries. Chemotherapy or combined modality therapy, followed by restaging with PET/CT to assess treatment response using the Deauville criteria (5-point scale), is the standard initial treatment for patients with newly diagnosed CHL. Brentuximab vedotin, a CD30-directed antibody-drug conjugate, has produced encouraging results in the treatment of relapsed or refractory disease. The potential long-term effects of treatment remain an important consideration, and long-term follow-up is essential after completion of treatment.",
author = "Hoppe, {Richard T.} and Advani, {Ranjana H.} and Ai, {Weiyun Z.} and Ambinder, {Richard F.} and Patricia Aoun and Bello, {Celeste M.} and Benitez, {Cecil M.} and Bierman, {Philip J.} and Blum, {Kristie A.} and Robert Chen and Bouthaina Dabaja and Andres Forero and Gordon, {Leo I.} and Hernandez-Ilizaliturri, {Francisco J.} and Hochberg, {Ephraim P.} and Jiayi Huang and Johnston, {Patrick B.} and Nadia Khan and Maloney, {David G.} and Mauch, {Peter M.} and Monika Metzger and Moore, {Joseph O.} and David Morgan and Moskowitz, {Craig H.} and Carolyn Mulroney and Matthew Poppe and Rachel Rabinovitch and Stuart Seropian and Christina Tsien and Winter, {Jane N.} and Joachim Yahalom and Burns, {Jennifer L.} and Hema Sundar",
note = "Publisher Copyright: {\textcopyright} JNCCN - Journal of the National Comprehensive Cancer Network. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2015",
month = may,
day = "1",
doi = "10.6004/jnccn.2015.0075",
language = "English (US)",
volume = "13",
pages = "554--586",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "5",
}